Cowen Inc’s GSK GSK Stock Holding History

Cowen Inc’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	$1.83M	Buy	+36,660	New	+$1.84M	0.13%	121

Other funds holding GSK

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.78B AUM 5.83% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Cowen Inc's GSK Position: Q2 2019 in Review

Cowen Inc opened a new position in GSK (GSK) in Q2 2019: 36,660 shares worth $1.83M. The stake represents 0.13% of the portfolio and ranks #121 among its holdings.

804 funds tracked by Wall St. Rank hold GSK as of Q2 2019.

Cowen Inc held 36,660 shares of GSK worth $1.83M as of Q2 2019.
GSK was a new Cowen Inc position in Q2 2019.
GSK made up 0.13% of Cowen Inc's portfolio in Q2 2019, its #121 holding.
804 funds tracked by Wall St. Rank held GSK as of Q2 2019.

Based on Cowen Inc's 13F filing for Q2 2019, filed 14 Aug 2019.